Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Capital/Financing Update 2024

Nov 19, 2024

66262_rns_2024-11-19_65cc28f9-db75-466f-a4e5-53daaaedbd24.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [101 x 28] intentionally omitted <==

QUOTATION NOTICE: NZX MAIN BOARD RUA BIOSCIENCE LIMITED (“RUARA”)

Issuer:

Rua Bioscience Limited (“RUA”)

Ticker Code:

RUARA

ISIN:

NZRUAE0005S8

Details of Issue:

A pro-rata renounceable rights issue of 3 new shares for every 4 existing shares held on the Record Date.

Ratio (New : Existing):

3 : 4

Exercise Price:

NZ $0.025 per new share

Issue Price Payable:

In full on application

Registrar:

Settlement Status:

Computershare Investor Services Limited (“RMLT”) NZCDC Settlement System

Key Dates

Ex Rights Date:

Rights Commence Trading:

Record Date:

Letters of Entitlement sent to Shareholders:

Tuesday, 12 November 2024 Tuesday, 12 November 2024 5pm, Wednesday, 13 November 2024 Thursday, 14 November 2024

Retail Offer Opens:

Rights Quotation Ceases:

Retail Offer Closes:

Allotment and commencement of trading of New Shares (retail offer):

Thursday, 14 November 2024 Wednesday, 20 November 2024 Monday, 2 December 2024 Friday, 6 December 2024

==> picture [137 x 65] intentionally omitted <==

Mark Peterson Chief Executive Officer NZX Limited

19 11 2024